Affiliation:
1. Department of Pathology, Clinical Microbiology Division,1 and
2. Department of Medicine, Infectious Disease Division,2Northwestern Memorial Hospital and Northwestern University Medical School, Chicago, Illinois 60611
Abstract
ABSTRACT
Bactericidal testing historically has exhibited variable reproducibility, even when prior standardized methods were employed. Several modifications to the National Committee for Clinical Laboratory Standards (NCCLS) broth macrodilution method are proposed to improve reproducibility. Recommended changes from the approved NCCLS guidelines (M21-A and M26-A) include omitting serum supplementation of Mueller-Hinton broth, incubating tubes at 35°C for 24 h with no agitation until they are sampled, running all tests in duplicate with six dilutions instead of nine, reincubating the test for an additional 24 h to resolve discrepant bactericidal activity test results, using a single 0.1-ml sample from each clear tube for subculture, and adopting an alternate method for calculating endpoint determination. In order to test these recommendations in a clinical laboratory setting, we used the modified methodology on 224 separate tests for bactericidal activity. There were 102 serum bactericidal titer (SBT) and 122 minimum bactericidal concentration (MBC) assays performed. By defining reproducibility as agreement between duplicate tests ± 1 dilution, we found 207 of 224 tests (92%) were reproducible at the 24-h subculture point (94% for the SBT assay and 91% for the MBC assay). When the 17 assays with discrepant results were incubated an additional 24 h for a second subculture, only 1 of 224 tests (0.4%) remained discrepant. The method used is practical for a clinical laboratory that chooses to perform bactericidal activity testing and assures a high level of reproducibility between duplicate assays. The total cost of a test was approximately $25.00.
Publisher
American Society for Microbiology
Reference26 articles.
1. Anhalt
J. P.
Sabath
L. D.
Barry
A. L.
Special tests: bactericidal activity activity of antimicrobics in combination and detection of beta-lactamase production
Manual of Clinical Microbiology
3rd ed.
Lennette
E. H.
Ballows
A.
Hausler
W. J.
Jr.
1980
478
American Society for Microbiology
Washington D.C
2. The prospects of treatment failure in the chemotherapy of infectious diseases in the 1990s;Armstrong D.;Microb. Drug Resist.,1995
3. Ciprofloxacin, azlocillin, ceftizoxime, and amikacin alone and in combination against gram-negative bacilli in an infected chamber model;Bamberger D. M.;J. Antimicrob. Chemother.,1986
4. Removal of fatty acids from serum albumin by charcoal treatment;Chen R. F.;J. Biol. Chem.,1967
5. Antimicrobial susceptibility tests and their role in therapeutic drug monitoring;DeGirolani P. C.;Clin. Lab. Med.,1987
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献